A supplier network fraying at the edges can eventually break down into a full-blown disruptive crisis. With global debt soaring, daily bankruptcy risk evaluation is a must.
Resources
Stay ahead of public company risk with our bankruptcy case studies, high risk reports, blogs and more.
Major drug manufacturers Mallinckrodt plc and Endo International plc are financially distressed due to elevated debt and product-related risks. If your company is doing business with these manufacturers, you should evaluate your risk exposure and perform further research.
CreditRiskMonitor reported operating revenues of $4.55 million, an increase of 5%, for the three months ended Sept. 30, 2022, as compared to the third quarter of fiscal 2021.
CreditRiskMonitor reported operating revenues of $4.45 million, an increase of approximately $202 thousand or 5%, for the three months ended June 30, 2022, as compared to the second quarter of fiscal 2021.
CreditRiskMonitor reported operating revenues of $4.8 million, an increase of approximately $245 thousand or 5%, for the third quarter of fiscal 2023 compared to the same period of fiscal 2022.
CreditRiskMonitor today announced a new licensing agreement with DBRS, an independent, privately-held, globally recognized credit agency.
CreditRiskMonitor (OTCQX: CRMZ) reported that for the three months ended March 31, 2018 revenues increased 4% to $3.37 million compared to $3.24 million in last year’s first quarter.
CreditRiskMonitor® reported operating revenues of $4.7 million, an increase of approximately $232 thousand or 5%, for the second quarter of fiscal 2023 compared to the same period of fiscal 2022.
CreditRiskMonitor reported that revenues were $3.48 million and $10.33 million for the three and nine months ended Sept. 30, 2018, respectively, an increase of 2.8% and 3.7% over the comparable periods last year.